在住院期间优化心力衰竭的指导方针导向医疗疗法,减少在住院期间的喷射分数
Neal M Dixit1, Shivani Shah2, Boback Ziaeian1,3,4
1Department of Medicine, David Geffen School of Medicine at UCLA Los Angeles, CA.
US cardiology
|December 25, 2024
概括
针对心力衰竭的指导指导医学疗法 (GDMT) 与减少喷射分数 (HFrEF) 往往未得到充分利用. 本指南详细介绍了在住院期间实施四种关键的HFrEF疗法,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 减少喷射分数 (HFrEF) 的心力衰竭对社会构成重大负担,直接成本高,患者的治疗结果低于最佳.
- 尽管已证明有好处,但针对HFrEF的指南导向医学治疗 (GDMT) 在门诊环境中经常被低估或低估.
- 住院治疗为优化适合患者的GDMT启动和定位提供了一个关键机会.
研究的目的:
- 为在急性心力衰竭住院期间实施GDMT的四个基本支柱提供实用指南.
- 为弥补HFrEF患者GDMT利用的差距.
- 促进及时有效地启动基于证据的治疗方法.
主要方法:
- 该指南侧重于对HFrEF的四种关键基于证据的治疗方法的实际实施.
- 这些疗法包括氨酸- ангиотензин- алдостерон系统抑制剂 (含或不含 neprilysin 抑制剂),β 阻断剂,矿物质皮质糖类受体对抗剂和-葡萄糖共传递体-2 抑制剂.
- 该策略强调在急性心力衰竭入院期间启动和定位.
主要成果:
- 这四种基础疗法在开始后的30天内提供临床效益.
- 在住院期间实施这些疗法可以克服门诊患者启动的挑战.
- 这种方法旨在改善HFrEF的坚持和优化治疗.
结论:
- 在急性心力衰竭住院期间优化GDMT对于改善HFrEF患者的治疗结果至关重要.
- 对启动和定位GDMT四个支柱的结构化方法可以提高治疗效率.
- 本实用指南支持临床医生最大限度地提高GDMT对HFrEF患者的益处.
更多相关视频
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
01:22Heart Failure Drugs: β-Blockers
259
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
259
01:22Heart Failure Drugs: Diuretics
275
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
275
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
398
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
398
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
95
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
95